No feed items found.
August 13, 2017 / Healthcare
Neurocrine and BIAL Announce Exclusive North American Licensing Agreement of Opicapone for $145M
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) and BIAL today announced that they have entered into an exclusive licensing agreement for the development and commercialization of opicapone in North America.
Read More
August 13, 2017 / Healthcare
Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion
Botox maker Allergan Plc agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people slim down by freezing fat away to the company's line-up of aesthetic products.
Read More
August 10, 2017 / Healthcare
FDA accepts Merck application for lung cancer combo therapy
Merck & Co on Tuesday said the FDA agreed to a speedy review of its application to combine its immunotherapy...
Read More
August 10, 2017 / Finance
Gundlach: ‘trouble’ for U.S. stocks if 10-year yield hits above 3 percent
There will be "trouble for equity markets" if the yield on the benchmark 10-year U.S. Treasury note moves beyond 3...
Read More
January 9, 2017 / Finance
Wall Street Is Starting to Get Nervous About All the Money Pouring Into U.S. Stocks
After President-elect Donald Trump won the election, markets began a decisive shift in essentially all asset classes. Suddenly, everything from bank stocks to emerging-market...
Read More
January 9, 2017 / Healthcare
France’s Ipsen to buy some Merrimack assets for up to $1 billion
French drugmaker Ipsen SA (IPN.PA) said on Monday it would buy some assets of U.S. peer Merrimack Pharmaceuticals Inc (MACK.O),...
Read More
January 3, 2017 / Healthcare
New drug approvals fall to a six-year low in 2016
Last year turned out to be a disappointing one for new drug approvals with the U.S. Food and Drug Administration clearing just 22 new medicines for sale, the lowest number since 2010 and sharply down on 2015's tally of 45.
Read More
January 2, 2017 / Healthcare
U.S. FTC requires divestitures in $13.53 billion Boehringer-Sanofi deal
German pharmaceutical company Boehringer Ingelheim agreed to divest five types of animal health products to settle charges that a proposed asset swap with Sanofi would harm competition, the U.S. Federal Trade Commission said on Wednesday.
Read More
January 2, 2017 / Finance
The European Union Is Bailing Out Banks Again
Monte dei Paschi di Siena (MPS), the centuries-old bank that is drowning under a growing pile of distressed loans. Since the private sector has now refused to cough up enough capital to close the shortfall identified in this year’s stress tests, it is to be provided with 8.8bn euros of new equity capital, most of it by Italian taxpayers.
Read More
December 22, 2016 / Finance
Goldman, JPMorgan to invest in blockchain startup Axoni: sources
Goldman Sachs Group Inc, JPMorgan Chase & Co and a group of other financial institutions including inter-dealer broker ICAP Plc's venture arm are finalizing an investment in blockchain startup Axoni, people familiar with the deal said this week.
Read More